Company intelligence / Profile preview

DÁVI II

São Paulo, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

DÁVI (Diálise e Assistência à Vida) is a specialized healthcare provider based in Brazil that focuses on nephrology and renal replacement therapies. The company operates multiple dialysis centers, including the DÁVI II unit, providing hemodialysis and peritoneal dialysis services to patients with chronic kidney disease. DÁVI was acquired by Fresenius Medical Care, a global leader in products and services for individuals with renal diseases, to expand its service network in the Brazilian market. The centers are equipped to provide high-quality clinical care and support for patients requiring long-term renal management.

Therapeutic areas: Nephrology
Modalities: Non-pharmacological therapyDevice
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on DÁVI II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DÁVI II.

Explore the full profile